Shares of IperionX Limited Sponsored ADR (NASDAQ:IPX – Get Free Report) have earned an average rating of “Moderate Buy” from the six analysts that are covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation and five have given a buy recommendation to the company. The average 12-month price target among analysts that have covered the stock in the last year is $60.3333.
Several research firms have recently weighed in on IPX. Weiss Ratings reissued a “sell (e+)” rating on shares of IperionX in a report on Tuesday, April 21st. Alliance Global Partners restated a “buy” rating on shares of IperionX in a research note on Tuesday, April 28th. B. Riley Financial reduced their price objective on IperionX from $58.00 to $52.00 and set a “buy” rating for the company in a research note on Friday, March 13th. Roth Mkm restated a “buy” rating on shares of IperionX in a research note on Monday. Finally, BTIG Research upped their price objective on IperionX from $40.00 to $55.00 and gave the stock a “buy” rating in a research note on Friday.
View Our Latest Research Report on IPX
Insider Buying and Selling at IperionX
Institutional Investors Weigh In On IperionX
A number of institutional investors have recently bought and sold shares of IPX. Jones Financial Companies Lllp purchased a new stake in IperionX in the 3rd quarter worth $36,000. JPMorgan Chase & Co. purchased a new stake in IperionX in the 2nd quarter worth $66,000. State of Tennessee Department of Treasury purchased a new stake in IperionX in the 4th quarter worth $119,000. DV Equities LLC purchased a new position in IperionX in the 4th quarter worth approximately $178,000. Finally, Man Group plc bought a new position in IperionX in the 4th quarter worth approximately $257,000. Hedge funds and other institutional investors own 2.76% of the company’s stock.
IperionX Stock Down 0.8%
NASDAQ IPX opened at $36.04 on Wednesday. The business’s fifty day moving average price is $34.57 and its 200-day moving average price is $38.08. The company has a debt-to-equity ratio of 0.03, a current ratio of 4.03 and a quick ratio of 4.00. IperionX has a 1-year low of $21.66 and a 1-year high of $61.45.
IperionX (NASDAQ:IPX – Get Free Report) last released its quarterly earnings results on Saturday, January 31st. The company reported ($0.50) earnings per share for the quarter. As a group, research analysts anticipate that IperionX will post -0.12 EPS for the current year.
IperionX Company Profile
IperionX (NASDAQ: IPX) is a mineral technology company focused on the production and commercialization of high‐purity titanium and zirconium products. The company’s core activities include the development of advanced mineral sands projects and the deployment of proprietary processing technologies aimed at supplying feedstocks to aerospace, defense, additive manufacturing and battery markets.
At the heart of IperionX’s operations is the Stony Creek Project in Virginia, where the company holds significant mineral sands rights.
Read More
- Five stocks we like better than IperionX
- The Bank of Mom and Dad Is Booming—3 Stocks to Watch
- Corning Is Paving AI’s Future With Glass
- Why’s Amazon Suddenly Lagging the S&P 500, and Is It a Warning?
- Crypto Winter Is Here: 3 Stocks To Put On Ice This Summer
Receive News & Ratings for IperionX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IperionX and related companies with MarketBeat.com's FREE daily email newsletter.
